1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
Avanza Global
Fee
0.11%
ISIN
SE0011527613
Holdings
25
Number of owning funds
4
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Avanza Global, we have 39 holdings where Microsoft is the largest holding (4.71), followed by Apple (4.69) and Nvidia (2.86).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Avanza Global.
| UBS Lux Equity Fund Biotech USD | Avanza Global |
|---|---|
|
10.04 % |
 4.71 % |
|
9.21 % |
4.69 % |
|
4.66 % |
2.86 % |
|
4.13 % |
2.56 % |
|
3.75 % |
1.67 % |
| - |
1.4 % |
| - |
1.25 % |
| - |
0.96 % |
| - |
0.9 % |
| - |
0.87 % |
| - |
0.84 % |
| - |
0.82 % |
| - |
0.77 % |
| - |
0.71 % |
| - |
0.66 % |
| - |
 0.63 % |
| - |
0.62 % |
| - |
0.61 % |
| - |
 0.61 % |
| - |
0.59 % |
| - |
0.59 % |
| - |
 0.52 % |
| - |
0.51 % |
| - |
0.5 % |
| - |
 0.47 % |
The list of fund holdings was last updated on September 10, 2025.
